Product details
图文详情
It is the drug of first choice for treating gout, mainly used to inhibit uric acid synthesis. Clinically used for primary and secondary hyperuricemia, especially those with excessive uric acid production, also used for hyperuricemia with bone dysfunction; used to treat gout, suitable for patients with recurrent or invasive gout. Used in patients with gouty nephropathy, it can alleviate symptoms and reduce the formation of uric acid kidney stones; tophi, used for uric acid kidney stones and urate nephropathy.
In July 2016, the annual production capacity of 300 tons of calcium hydroxymethanesulfonate raw materials workshop was successfully built, and in September of the same year, the production line of 5-nitrovanillin diethyl acetal with an annual output of 400 tons was also successfully built. In April 2017, the company's main product, calcium hydroxymethanesulfonate, obtained the GMP certificate for raw materials (Certificate No.: HB20170336). In 2018, the production line of 60 tons of high sulfuric acid was built and put into production. In 2019, the production lines of 20 tons of colchosterol and 300 tons of betaine were successfully built and put into production, forming a new trend of project diversification and product diversification in the pharmaceutical field of our company.
The previous:
Next:
Related products
图文详情
Linagliptin and Metformin Extended-Release Tablets
β-Nicotinamide mononucleotide (NMN)
Allopurinol sustained-release capsules
Lactulose Oral Solution
Calcium dobesilate （with GMP,DMF open and closed parts）
Allopurinol （with GMP,DMF open and closed parts）
Product Inquiry
*Please keep your phone line open, we will contact you within 24 hours.
Carefully develop drugs with special indications using proprietary technology
Customer Service Hotline
Official website: www.hbgcyy.cn
Address: No. 19, Biopark 2nd Road, Biopark Industrial Park, High-tech Zone, Yichang City.
This website supports both IPV4 and IPV6 access.
Copyright © 2023 Guangchen Pharmaceutical ALL RIGHTS RESERVED.